Literature DB >> 21696910

The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.

N P Karikoski1, I Horn, T W McGowan, C M McGowan.   

Abstract

Endocrinopathic causes of laminitis may be a common underlying causative pathogenesis in first-opinion or field cases presenting with laminitis, as opposed to laminitis produced in inflammatory research models. This study aimed to determine whether evidence of an underlying endocrinopathy was present in horses presented for laminitis to a first-opinion/referral veterinary teaching hospital. A second aim was to compare the signalment of horses and ponies with laminitis with the equine hospital population during the same period. All horses presenting for laminitis at Helsinki University Equine Teaching Hospital, Finland, over a 16-month period were examined for an underlying endocrinopathy. Horses presenting for laminitis were compared with the hospitalized population over the same period. There were 36 horses presented for laminitis, and evidence of endocrinopathy was present in 89%. Of the horses showing an underlying endocrinopathy, one-third had a diagnosis of pituitary pars intermedia dysfunction, and two-thirds showed basal hyperinsulinemia indicative of insulin resistance, without evidence of hirsutism. Phenotypic indicators of obesity were present in 95% of horses with basal hyperinsulinemia without hirsutism. Compared with the hospital population during the same period, horses with laminitis associated with an underlying endocrinopathy were significantly older and more likely to be pony breeds. Our data support that endocrine testing should be performed on all cases of laminitis that do not have a clear inflammatory or gastrointestinal origin.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21696910     DOI: 10.1016/j.domaniend.2011.05.004

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  21 in total

1.  The effect of tumour necrosis factor-α and insulin on equine digital blood vessel function in vitro.

Authors:  Nicola J Menzies-Gow; H Wray; S R Bailey; P A Harris; J Elliott
Journal:  Inflamm Res       Date:  2014-04-24       Impact factor: 4.575

2.  Comparison of the glucose and insulin responses of horses to 2 formulations of corn syrup.

Authors:  Kira Moser; Heidi Banse
Journal:  Can Vet J       Date:  2019-06       Impact factor: 1.008

3.  Relationship of oxidative stress in skeletal muscle with obesity and obesity-associated hyperinsulinemia in horses.

Authors:  Heidi E Banse; Nicholas Frank; Grace P S Kwong; Dianne McFarlane
Journal:  Can J Vet Res       Date:  2015-10       Impact factor: 1.310

4.  Metabogenomics reveals four candidate regions involved in the pathophysiology of Equine Metabolic Syndrome.

Authors:  Laura Patterson Rosa; Martha F Mallicote; Maureen T Long; Samantha A Brooks
Journal:  Mol Cell Probes       Date:  2020-07-10       Impact factor: 2.365

Review 5.  Equine metabolic syndrome.

Authors:  R Morgan; J Keen; C McGowan
Journal:  Vet Rec       Date:  2015-08-15       Impact factor: 2.695

6.  Mouldable, thermoplastic, glue-on frog-supportive shoes change hoof kinetics in normal and obese Shetland ponies.

Authors:  J Sleutjens; F M Serra Bragança; M W van Empelen; R E Ten Have; J de Zwaan; E Roelfsema; M Oosterlinck; W Back
Journal:  Equine Vet J       Date:  2018-02-12       Impact factor: 2.888

7.  Effect of digital hypothermia on lamellar inflammatory signaling in the euglycemic hyperinsulinemic clamp laminitis model.

Authors:  Simon M Stokes; Teresa A Burns; Mauria R Watts; François-René Bertin; Darko Stefanovski; Carlos E Medina-Torres; James K Belknap; Andrew W van Eps
Journal:  J Vet Intern Med       Date:  2020-06-25       Impact factor: 3.333

8.  The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.

Authors:  Alexandra Meier; Dania Reiche; Melody de Laat; Christopher Pollitt; Donald Walsh; Martin Sillence
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

9.  Vascular Dysfunction in Horses with Endocrinopathic Laminitis.

Authors:  Ruth A Morgan; John A Keen; Brian R Walker; Patrick W F Hadoke
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

Review 10.  Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management.

Authors:  Caroline W Spelta
Journal:  Vet Med (Auckl)       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.